Stay updated on Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial
Sign up to get notified when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.

Latest updates to the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page
- CheckyesterdayChange DetectedAdded a dedicated 'Locations' section with Alabama as the study site and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now lists Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the government funding/operating status notice from the page. The core trial information remains unchanged.SummaryDifference0.4%

- Check52 days agoChange DetectedThe new screenshot shows only minor UI refinements compared with the old screenshot, with no changes to study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check80 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference3%

- Check87 days agoChange DetectedVersion updated to v3.1.0 with removal of several drug-safety-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a prior version tag v3.0.2 removed; indicates a restructuring and potential narrowing of content on drug quality topics.SummaryDifference0.4%

Stay in the know with updates to Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belimumab in Emphysema With Anti-GRP78 Autoantibodies Clinical Trial page.